BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38340381)

  • 1. Blockade of isoprenoids biosynthesis by simvastatin induces autophagy-mediated cell death via downstream c-Jun N-terminal kinase activation and cell cycle dysregulation in canine T-cell lymphoma cells.
    Kobayashi K; Baba K; Kambayashi S; Okuda M
    Res Vet Sci; 2024 Mar; 169():105174. PubMed ID: 38340381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of simvastatin on cell proliferation and Ras activation in canine tumour cells.
    Kobayashi K; Baba K; Kambayashi S; Okuda M
    Vet Comp Oncol; 2021 Mar; 19(1):99-108. PubMed ID: 32779819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis, autophagy and ER stress in mevalonate cascade inhibition-induced cell death of human atrial fibroblasts.
    Ghavami S; Yeganeh B; Stelmack GL; Kashani HH; Sharma P; Cunnington R; Rattan S; Bathe K; Klonisch T; Dixon IM; Freed DH; Halayko AJ
    Cell Death Dis; 2012 Jun; 3(6):e330. PubMed ID: 22717585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin induces proliferation inhibition and apoptosis in C6 glioma cells via c-jun N-terminal kinase.
    Koyuturk M; Ersoz M; Altiok N
    Neurosci Lett; 2004 Nov; 370(2-3):212-7. PubMed ID: 15488325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simvastatin inhibition of mevalonate pathway induces apoptosis in human breast cancer cells via activation of JNK/CHOP/DR5 signaling pathway.
    Gopalan A; Yu W; Sanders BG; Kline K
    Cancer Lett; 2013 Feb; 329(1):9-16. PubMed ID: 22960596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMG-CoA reductase inhibitor simvastatin overcomes bortezomib-induced apoptosis resistance by disrupting a geranylgeranyl pyrophosphate-dependent survival pathway.
    Fuchs D; Berges C; Opelz G; Daniel V; Naujokat C
    Biochem Biophys Res Commun; 2008 Sep; 374(2):309-14. PubMed ID: 18625202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering the signaling networks underlying simvastatin-induced apoptosis in human cancer cells: evidence for non-canonical activation of RhoA and Rac1 GTPases.
    Zhu Y; Casey PJ; Kumar AP; Pervaiz S
    Cell Death Dis; 2013 Apr; 4(4):e568. PubMed ID: 23559002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin inhibits growth via apoptosis and the induction of cell cycle arrest in human melanoma cells.
    Saito A; Saito N; Mol W; Furukawa H; Tsutsumida A; Oyama A; Sekido M; Sasaki S; Yamamoto Y
    Melanoma Res; 2008 Apr; 18(2):85-94. PubMed ID: 18337644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMG-CoA reductase inhibitors induce apoptosis of lymphoma cells by promoting ROS generation and regulating Akt, Erk and p38 signals via suppression of mevalonate pathway.
    Qi XF; Zheng L; Lee KJ; Kim DH; Kim CS; Cai DQ; Wu Z; Qin JW; Yu YH; Kim SK
    Cell Death Dis; 2013 Feb; 4(2):e518. PubMed ID: 23449454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mevalonate Cascade Inhibition by Simvastatin Induces the Intrinsic Apoptosis Pathway via Depletion of Isoprenoids in Tumor Cells.
    Alizadeh J; Zeki AA; Mirzaei N; Tewary S; Rezaei Moghadam A; Glogowska A; Nagakannan P; Eftekharpour E; Wiechec E; Gordon JW; Xu FY; Field JT; Yoneda KY; Kenyon NJ; Hashemi M; Hatch GM; Hombach-Klonisch S; Klonisch T; Ghavami S
    Sci Rep; 2017 Mar; 7():44841. PubMed ID: 28344327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipophilic but not hydrophilic statins selectively induce cell death in gynaecological cancers expressing high levels of HMGCoA reductase.
    Kato S; Smalley S; Sadarangani A; Chen-Lin K; Oliva B; Brañes J; Carvajal J; Gejman R; Owen GI; Cuello M
    J Cell Mol Med; 2010 May; 14(5):1180-93. PubMed ID: 19432822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of eIF2α attenuates statin-induced apoptosis by inhibiting the stabilization and translocation of p53 to the mitochondria.
    Lee SK; Kim YS
    Int J Oncol; 2013 Mar; 42(3):810-6. PubMed ID: 23354132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin exerts anticancer effects in osteosarcoma cell lines via geranylgeranylation and c-Jun activation.
    Kany S; Woschek M; Kneip N; Sturm R; Kalbitz M; Hanschen M; Relja B
    Int J Oncol; 2018 Apr; 52(4):1285-1294. PubMed ID: 29532878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simvastatin exhibits antiproliferative effects on spheres derived from canine mammary carcinoma cells.
    Torres CG; Olivares A; Stoore C
    Oncol Rep; 2015 May; 33(5):2235-44. PubMed ID: 25778435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin induces apoptosis in human breast cancer cells: p53 and estrogen receptor independent pathway requiring signalling through JNK.
    Koyuturk M; Ersoz M; Altiok N
    Cancer Lett; 2007 Jun; 250(2):220-8. PubMed ID: 17125918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ophiopogonin B induces the autophagy and apoptosis of colon cancer cells by activating JNK/c-Jun signaling pathway.
    Gao GY; Ma J; Lu P; Jiang X; Chang C
    Biomed Pharmacother; 2018 Dec; 108():1208-1215. PubMed ID: 30372822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
    Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
    J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of AMPK-dependent autophagy enhances in vitro antiglioma effect of simvastatin.
    Misirkic M; Janjetovic K; Vucicevic L; Tovilovic G; Ristic B; Vilimanovich U; Harhaji-Trajkovic L; Sumarac-Dumanovic M; Micic D; Bumbasirevic V; Trajkovic V
    Pharmacol Res; 2012 Jan; 65(1):111-9. PubMed ID: 21871960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of an HMG-CoA reductase inhibitor, simvastatin, on human myeloma cells.
    Otsuki T; Sakaguchi H; Hatayama T; Fujii T; Tsujioka T; Sugihara T; Takata A; Hyodoh F; Eto M
    Oncol Rep; 2004 May; 11(5):1053-8. PubMed ID: 15069546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HMG-CoA inhibitor, simvastatin, triggers in vitro anti-tumour effect and decreases IgM secretion in Waldenstrom macroglobulinaemia.
    Moreau AS; Jia X; Patterson CJ; Roccaro AM; Xu L; Sacco A; O'Connor K; Soumerai J; Ngo HT; Hatjiharissi E; Hunter ZR; Ciccarelli B; Manning R; Ghobrial IM; Leleu X; Treon SP
    Br J Haematol; 2008 Sep; 142(5):775-85. PubMed ID: 18537966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.